Abstract
The development of drug delivery systems in experimental therapy usually requires in vitro release models, that should posses specific characteristics including: low cost, simple procedure, high reproducibility and very importantly resemble as strictly as possible the in vivo behaviour. In this respect, the paper describes the effects of the use of different experimental procedures on the drug release profiles from controlled delivery formulations based on nano and micro systems. As examples of micro and nanosystems, microparticles constituted of poly-lactide-co-glycolide (PEM) or gelatine (GEM) and nanostructured lipid carriers (NLC) or cubosomes (CBS) were selected, respectively. All the analysed formulations contained bromocriptine (BC) that represents a poorly water-soluble drug. The influence of the experimental release method and of release media has been investigated using different experimental set-up including direct and reverse dialysis, flow-through cell, USP XXII paddle and Franz cell methods.
Keywords: Drug delivery formulations, Microsystems, Nanosystems, Drug release profiles
Current Analytical Chemistry
Title:Analysis of the Drug Release Profiles from Formulations Based on Micro and Nano Systems
Volume: 9 Issue: 1
Author(s): Elisabetta Esposito, Stefania Mazzitelli, Rita Cortesi, Markus Drechsler, Laura Ravani, Claudio Nastruzzi
Affiliation:
Keywords: Drug delivery formulations, Microsystems, Nanosystems, Drug release profiles
Abstract: The development of drug delivery systems in experimental therapy usually requires in vitro release models, that should posses specific characteristics including: low cost, simple procedure, high reproducibility and very importantly resemble as strictly as possible the in vivo behaviour. In this respect, the paper describes the effects of the use of different experimental procedures on the drug release profiles from controlled delivery formulations based on nano and micro systems. As examples of micro and nanosystems, microparticles constituted of poly-lactide-co-glycolide (PEM) or gelatine (GEM) and nanostructured lipid carriers (NLC) or cubosomes (CBS) were selected, respectively. All the analysed formulations contained bromocriptine (BC) that represents a poorly water-soluble drug. The influence of the experimental release method and of release media has been investigated using different experimental set-up including direct and reverse dialysis, flow-through cell, USP XXII paddle and Franz cell methods.
Export Options
About this article
Cite this article as:
Elisabetta Esposito, Stefania Mazzitelli, Rita Cortesi, Markus Drechsler, Laura Ravani, Claudio Nastruzzi , Analysis of the Drug Release Profiles from Formulations Based on Micro and Nano Systems, Current Analytical Chemistry 2013; 9 (1) . https://dx.doi.org/10.2174/1573411011309010037
DOI https://dx.doi.org/10.2174/1573411011309010037 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in the Development of Anti-Infective Prophylactic and/or Therapeutic Agents Based on Toll-Like Receptor (TLRs)
Recent Patents on Anti-Infective Drug Discovery Do We Need More Research on Platelet Function in South Asian Immigrants?
Inflammation & Allergy - Drug Targets (Discontinued) Role of Androgens in Womens Sexual Function & Dysfunction: What Have We Learned in Six Decades?
Current Women`s Health Reviews Inhalation Delivery of Protein Therapeutics
Inflammation & Allergy - Drug Targets (Discontinued) New Pharmacological Perspectives and Therapeutic Potential of PPAR-γ Agonists
Current Pharmaceutical Design Current Management of Neonatal Neuroblastoma
Current Pediatric Reviews Probiotics: From Functional Foods to Pharmaceutical Products
Current Pharmaceutical Biotechnology Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice
Current Pediatric Reviews Mitochondrial Serine Protease HtrA2/Omi as a Potential Therapeutic Target
Current Drug Targets Sepsis, Coagulation and Anticoagulants
Endocrine, Metabolic & Immune Disorders - Drug Targets Dopamine Receptor Pharmacology: Interactions with Serotonin Receptors and Significance for the Aetiology and Treatment of Schizophrenia
CNS & Neurological Disorders - Drug Targets Fluid and Electrolyte Disorders in the Newborn: Sodium and Potassium
Current Pediatric Reviews Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review
Current Genomics A Nanoparticle-Encapsulated Non-Nucleoside Reverse-Transcriptase Inhibitor with Enhanced Anti-HIV-1 Activity and Prolonged Circulation Time in Plasma
Current Pharmaceutical Design Recent Developments in Drug Targets and Delivery of Anti-HIV Drugs
Infectious Disorders - Drug Targets Immunosuppression in Liver Transplantation
Current Drug Targets Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Immune Responses to Lentiviral Vectors
Current Gene Therapy Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.
Anti-Infective Agents in Medicinal Chemistry Genetics and Vaccines in the Era of Personalized Medicine
Current Genomics